Bryan Blickhan

Dallas Biotech Lupagen Partners With Global Transfusion Leader to Advance Bedside Cell and Gene Therapy

by | Sep 18, 2023
The deal with Fresenius Kabi aims to bring innovative cell and gene treatments closer to patients by advancing Lupagen’s proprietary cell and gene therapy delivery system, the companies said. Their "to the bedside" approach could help open cutting-edge treatments to local hospitals and patients worldwide.
MORE